Share

Top Quality MSM Glucosamine Chondroitin [...]
34.50€




Molybdenum

Molybdenum is an essential trace mineral in animal and human nutrition. It is found in several tissues of the human body and is required for the activity of some enzymes that are involved in catabolism, including the catabolism of purines and the sulfur amino acids.
Compounds of molybdenum are among the scarcer constituents of the earth's crust. In fact, molybdenum is only about three times more abundant than gold. The principal ore of molybdenum is molybdenite (molybdenum disulfide). Organic forms of molybdenum are found in living matter, from bacteria to animals, including humans.

In spite of its low abundance, molybdenum deficiency in humans is rare but it has been described. A patient on long-term total parenteral nutrition (TPN) developed a syndrome characterized by hypouricemia, hypermethioninemia, low urinary sulfate excretion, tachycardia, tachypnea and mental and visual disturbances.

Animals can be made molybdenum deficient by feeding them diets containing high amounts of tungsten or copper. Both tungsten and copper are molybdenum antagonists. Molybdenum deficiency has also been produced experimentally in goats by feeding them purified diets, very low in molybdenum. Molybdenum deficiency in animals results in retarded weight gain, decreased food consumption, impaired reproduction and a shortened life expectancy.

Molybdenum prevents and treats molybdenum deficiency. Molybdenum has putative anticarcinogenic activity.

Except for evidence of supplemental molybdenum's usefulness in some individuals made deficient due to prolonged total parenteral nutrition, research to date has revealed no further indications for the supplemental use of molybdenum.

An epidemiologic association has been made between the high incidence of esophageal cancer and the low intake of molybdenum in an area of China. In one study, supplementing some of those who live in this area with molybdenum for prolonged periods did not lower the incidence of cancer, although supplementation with beta carotene, vitamin E and selenium did reduce the incidence of some cancers in this study group.

                                                     MOLYBDENUM
Main Uses and Actions: supplements molybdenum deficiency
Standard Dosage: 75 mcg daily
Contraindications:
  • Molybdenum is contraindicated in those who are hypersensitive to any component of a molybdenum-containing product.
  • Pregnant women and nursing mothers should avoid the use of supplemental molybdenum greater than recommended amounts (75 micrograms daily)
Drug Interactions:
  • High doses of molybdate may inhibit the metabolism of acetaminophen,
  • High doses of molybdate may antagonize the absorption of copper. Likewise, high doses of copper may antagonize the absorption of molybdenum and overall decrease molybdenum status.



Bibliography

Anon. Molybdenum deficiency in TPN. Nutr Rev. 1987; 45:337-341.
Barceloux DG. Molybdenum. J Toxicol Clin Toxicol. 1999; 37:231-237.
Barch DH. Esophageal cancer and microelements. J Am Coll Nutr. 1989; 8:99-107.
Beedham C. Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab Rev. 1985; 16:119-156.
Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993; 85:1483-1492.
Boles JW, Klaassen CD. Effects of molybdate and pentachlorophenol on the sulfation of acetaminophen. Toxicology. 2000; 146:23-35.
Brewer GJ, Dick RD, Grover DK, et al. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin Cancer Res. 2000; 6:1-10.
Brewer GJ, Johnson V, Dick RD, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 1996; 53:1017-1025.
Edwards MC, Johnson JL, Marriage B, et al. Isolated sulfite oxidase deficiency: review of two cases in one family. Ophthalmology. 1999; 106:1957-1961.
Hille R. Molybdenum enzymes. Essays Biochem. 1999; 34:125-137.
Johnson JL, Cohen HJ, Rajagopalan KV. Molecular basis of the biological function of molybdenum. J Biol Chem. 1974; 249:5046-5055.
Johnson JL, Waud WR, Rajagopalan KV, et al. Inborn errors of molybdenum metabolism: Combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor. Proc Natl Acad Sci USA. 1980; 77:3715-3719.
Luo XM, Wei HJ, Hu GG, et al. Molybdenum and esophageal cancer in China. Federation Proceedings. 1981; 46:928(Abstract#3962).
Mendel RR. The role of the molybdenum cofactor in humans. Biofactors. 2000; 11:147-148.
Momcilovic B. A case of acute human molybdenum toxicity from a dietary molybdenum supplement—a new member of the "Lucor metallicum" family. Arh Hig Rada Toksikol. 1999; 50:289-297.
Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
Rajagopalan KV. Molybdenum—an essential trace element. Nutr Rev. 1987; 45:321-328.
Recommended Dietary Allowances. 10th Edition. Washington, DC: National Academy Press; 1989.
Thompson KH, Scott KC, Turnlund JR. Molybdenum metabolism in men with increasing molybdenum intakes: changes in kinetic parameters. J Appl Physiol. 1996; 81:1404-1409.
Turnland JR, Keyes WR, Peiffer GL. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men at five intakes of dietary molybdenum. Am J Clin Nutr. 1995; 62:790-796.
Vyskocil A, Viau C. Assessment of molybdenum toxicity in humans. J Appl Toxicol. 1999; 19:185-192.
Wuebbens MW, Liu MTW, Rajagopalan KV, Schlindelin H. Insights into molybdenum cofactor deficiency provided by the crystal structure of the molybdenum cofactor biosynthesis protein MoaC. Strucutre. 2000; 8:709-718.


WARNINGS: Information, statements and products on this website have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition. The natural properties of the botanicals are only referred to their common uses among folk and herbal traditions. Our products are not intended to diagnose, cure, or prevent any disease as well. It's not meant to give any suggestion of diagnosis or disease treatment. Please see a doctor when needed.